Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization

Riera-Montes, Margarita; Bollaerts, Kaatje; Heininger, Ulrich; Hens, Niel; Gabutti, Giovanni; Gil, Angel; Nozad, Bayad; Mirinaviciute, Grazina; Flem, Elmira; Souverain, Audrey; Verstraeten, Thomas; Hartwig, Susanne

doi:10.1186/s12879-017-2445-2

BMC Infectious Diseases

Table 6 Age-specific annual mortality incidence (/100,000) of varicella in European countries before the introduction of universal childhood immunization programs

From: Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization

Country	Annual incidence /100,000 (95% CI) per age group in years
Country	<5	5–9	10–14	15–19	20–39	40+
Austria	0.08 (0–1.06)	0 (0–0.91)	0 (0–0.89)	0 (0–0.81)	0 (0–0.17)	0 (0–0.09)
Belgium	0.13 (0–0.81)	0.02 (0–0.59)	0.02 (0–0.63)	0 (0–0.58)	0 (0–0.13)	0.02 (0–0.11)
Bulgaria	0.03 (0–1.16)	0 (0–1.08)	0 (0–1.16)	0 (0–1.17)	0 (0–0.2)	0 (0–0.09)
Croatia	0.09 (0–1.97)	0.04 (0–1.82)	0 (0–1.79)	0 (0–1.52)	0.01 (0–0.35)	0 (0–0.16)
Cyprus	0 (0–7.45)	0 (0–7.77)	0 (0–8.15)	0 (0–7)	0 (0–1.32)	0 (0–0.93)
Czech Rep.	0 (0–0.66)	0.02 (0–0.68)	0 (0–0.78)	0 (0–0.8)	0 (0–0.12)	0 (0–0.07)
Denmark	0.06 (0–1.36)	0 (0–1.11)	0 (0–1.11)	0 (0–1.05)	0 (0–0.26)	0 (0–0.13)
Estonia	0 (0–5.11)	0 (0–4.9)	0 (0–5.84)	0 (0–6.17)	0 (0–1.03)	0 (0–0.54)
Finland	0 (0–1.22)	0 (0–1.21)	0 (0–1.26)	0 (0–1.2)	0 (0–0.27)	0.03 (0–0.19)
France	0.07 (0.01–0.22)	0.02 (0–0.13)	0.01 (0–0.11)	0 (0–0.1)	0.01 (0–0.04)	0.02 (0.01–0.05)
Germany	0.03 (0–0.17)	0.01 (0–0.13)	0.01 (0–0.12)	0 (0–0.09)	0 (0–0.03)	0 (0–0.02)
Greece	0 (0–0.73)	0.02 (0–0.71)	0.02 (0–0.73)	0 (0–0.68)	0.03 (0–0.18)	0 (0–0.06)
Hungary	0.06 (0–0.95)	0.02 (0–0.79)	0 (0–0.77)	0 (0–0.71)	0.01 (0–0.15)	0 (0–0.08)
Iceland	0 (0–16.04)	0 (0–16)	0 (0–17.3)	0 (0–16.71)	0 (0–3.97)	0 (0–2.52)
Ireland	0 (0–1.04)	0.05 (0–1.17)	0 (0–1.19)	0 (0–1.26)	0 (0–0.29)	0.06 (0–0.3)
Italy	0.04 (0–0.2)	0.01 (0–0.14)	0.01 (0–0.15)	0 (0–0.14)	0.01 (0–0.04)	0.01 (0–0.02)
Latvia	0 (0–3.78)	0 (0–3.48)	0 (0–3.97)	0 (0–4.15)	0 (0–0.68)	0 (0–0.35)
Lithuania	0 (0–2.47)	0 (0–2.67)	0.06 (0–2.82)	0 (0–2.15)	0 (0–0.49)	0 (0–0.24)
Luxembourg	0 (0–11.45)	0 (0–11.66)	0 (0–11.59)	0 (0–10.99)	0 (0–2.3)	0 (0–1.35)
Malta	0 (0–17.66)	0 (0–18.37)	0 (0–18.16)	0 (0–15.28)	0 (0–3.02)	0 (0–1.69)
Netherlands	0.04 (0–0.5)	0.01 (0–0.42)	0.01 (0–0.39)	0 (0–0.37)	0 (0–0.09)	0.02 (0–0.08)
Norway	0 (0–1.18)	0 (0–1.16)	0 (0–1.2)	0 (0–1.13)	0.01 (0–0.28)	0.07 (0.01–0.27)
Poland	0.03 (0–0.25)	0.03 (0–0.23)	0 (0–0.2)	0 (0–0.19)	0 (0–0.04)	0 (0–0.03)
Portugal	0.03 (0–0.88)	0.03 (0–0.8)	0 (0–0.69)	0 (0–0.67)	0.02 (0–0.18)	0.01 (0–0.08)
Romania	0.09 (0–0.56)	0 (0–0.34)	0.01 (0–0.36)	0 (0–0.34)	0 (0–0.07)	0 (0–0.04)
Slovakia	0 (0–1.31)	0.04 (0–1.39)	0 (0–1.4)	0 (0–1.26)	0 (0–0.22)	0 (0–0.14)
Slovenia	0 (0–3.37)	0 (0–3.56)	0 (0–4.02)	0 (0–3.88)	0 (0–0.67)	0.02 (0–0.36)
Spain	0.06 (0–0.27)	0.02 (0–0.18)	0.01 (0–0.19)	0 (0–0.18)	0.03 (0.01–0.08)	0.01 (0–0.04)
Sweden	0.12 (0–0.86)	0.02 (0–0.69)	0.04 (0–0.79)	0 (0–0.7)	0 (0–0.15)	0.04 (0–0.14)
Switzerland	0.03 (0–0.94)	0.03 (0–0.96)	0 (0–0.92)	0 (0–0.84)	0 (0–0.17)	0.03 (0–0.14)
UK	0.11 (0.03–0.27)	0.03 (0–0.16)	0.01 (0–0.12)	0.01 (0–0.12)	0.02 (0–0.05)	0.05 (0.03–0.08)

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com